Application of quality by design to the development of analytical separation methods
暂无分享,去创建一个
[1] S Furlanetto,et al. Mixture-process variable approach to optimize a microemulsion electrokinetic chromatography method for the quality control of a nutraceutical based on coenzyme Q10. , 2012, Talanta.
[2] G. Derringer,et al. Simultaneous Optimization of Several Response Variables , 1980 .
[3] J. Cornell,et al. Experiments with Mixtures , 1992 .
[4] I. Molnár,et al. Aspects of the "Design Space" in high pressure liquid chromatography method development. , 2010, Journal of chromatography. A.
[5] K. Ishikawa. What is total quality control the japanese way , 2002 .
[6] Grady Hanrahan,et al. Chemometric experimental design based optimization techniques in capillary electrophoresis: a critical review of modern applications , 2008, Analytical and bioanalytical chemistry.
[7] Sandra Furlanetto,et al. Cyclodextrin-MEEKC for the analysis of oxybutynin and its impurities. , 2009, Talanta.
[8] H. Wu,et al. Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development. , 2011, International journal of pharmaceutics.
[9] I. Molnár,et al. Quality by Design: Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. , 2012, Journal of chromatography. A.
[10] Benjamin Debrus,et al. Development of a new predictive modelling technique to find with confidence equivalence zone and design space of chromatographic analytical methods , 2008 .
[11] Andre Raw,et al. Quality by Design: Concepts for ANDAs , 2008, The AAPS Journal.
[12] Evdokia Korakianiti,et al. Statistical Thinking and Knowledge Management for Quality-Driven Design and Manufacturing in Pharmaceuticals , 2011, Pharmaceutical Research.
[13] Heidi B. Goldfarb. Experiments with Mixtures, 3rd Ed. , 2002 .
[14] Benjamin Debrus,et al. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[15] Benjamin Debrus,et al. Application of new methodologies based on design of experiments, independent component analysis and design space for robust optimization in liquid chromatography. , 2011, Analytica chimica acta.
[16] S Furlanetto,et al. Mixture experiment methods in the development and optimization of microemulsion formulations. , 2011, Journal of pharmaceutical and biomedical analysis.
[17] K. Ishikawa. What Is Total Quality Control , 1985 .
[18] E. Rozet,et al. Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space. , 2011, Journal of chromatography. A.
[19] Alavattam Sreedhara,et al. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design. , 2011, Journal of pharmaceutical sciences.
[20] Frederick G Vogt,et al. Development of quality-by-design analytical methods. , 2011, Journal of pharmaceutical sciences.
[21] Sandra Furlanetto,et al. Pitfalls and success of experimental design in the development of a mixed MEKC method for the analysis of budesonide and its impurities , 2009, Electrophoresis.
[22] I. Molnár,et al. Expanding the term "Design Space" in high performance liquid chromatography (I). , 2011, Journal of pharmaceutical and biomedical analysis.
[23] Naseem A. Charoo,et al. Quality by design approach for formulation development: a case study of dispersible tablets. , 2012, International journal of pharmaceutics.
[24] Sarfaraz K. Niazi. Pharmaceutical Quality System , 2009 .
[25] Anurag S Rathore,et al. Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.
[26] J. Abraham. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .
[27] J. G. Rosas,et al. Quality by design approach of a pharmaceutical gel manufacturing process, part 1: determination of the design space. , 2011, Journal of pharmaceutical sciences.
[28] I. Molnár,et al. From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations , 2011 .
[29] Johannes G Khinast,et al. An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[30] D Brynn Hibbert,et al. Experimental design in chromatography: a tutorial review. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[31] Cyrus Agarabi,et al. Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate. , 2012, Journal of pharmaceutical and biomedical analysis.
[32] Diane J Burgess,et al. Quality by design approach to understand the process of nanosuspension preparation. , 2009, International journal of pharmaceutics.
[33] Roger Nosal,et al. API Quality by Design Example from the Torcetrapib Manufacturing Process , 2007, Journal of Pharmaceutical Innovation.
[34] Sandra Furlanetto,et al. Dual CD system‐modified MEEKC method for the determination of clemastine and its impurities , 2010, Electrophoresis.
[35] Sandra Furlanetto,et al. Development of a capillary electrophoresis method for the assay of ramipril and its impurities: an issue of cis-trans isomerization. , 2011, Journal of chromatography. A.
[36] Jérôme Mantanus,et al. Design space approach in the optimization of the spray-drying process. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[37] Pedro Hernandez-Abad,et al. Quality by design case study: an integrated multivariate approach to drug product and process development. , 2009, International journal of pharmaceutics.
[38] Bernard A Olsen,et al. A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603). , 2008, Journal of pharmaceutical and biomedical analysis.
[39] S Furlanetto,et al. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.